Are you Dr. Gould?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
550 Peachtree St Ne
7th Floor
Atlanta, GA 30308Phone+1 404-686-8114Fax+1 404-686-4841
Summary
- Dr. Carolyn Gould, MD is an infectious disease specialist in Atlanta, Georgia. She is currently licensed to practice medicine in Georgia and Pennsylvania. She is affiliated with Emory University Hospital Midtown, Grady Health System, and Emory University Hospital.
Education & Training
- University of Pennsylvania Health SystemFellowship, Infectious Disease, 2001 - 2003
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1998 - 2001
- Perelman School of Medicine at the University of PennsylvaniaClass of 1998
Certifications & Licensure
- GA State Medical License 2003 - 2025
- PA State Medical License 1999 - 2004
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 13 citationsWest Nile Virus Transmission by Solid Organ Transplantation and Considerations for Organ Donor Screening Practices, United States.Raymond A Soto, Emily McDonald, Pallavi Annambhotla, Jason O. Velez, Janeen Laven
Emerging Infectious Diseases. 2021-11-29 - Tick-borne encephalitis among US travellers, 2010-20.Susan L. Hills, Kelly R Broussard, James Broyhill, Lalita G Shastry, Caitlin M. Cossaboom
Journal of Travel Medicine. 2021-11-06 - 5 citationsCost-Effectiveness and Impact of a Targeted Age- and Incidence-based West Nile Virus Vaccine StrategyEmily J Curren, Manjunath B. Shankar, Marc Fischer, Martin I. Meltzer, J. Erin Staples
Clinical Infectious Diseases. 2021-11-02
Press Mentions
- Exceptional Nurse Manager Lulu Pearl Kwakye, MSN, MHA, BBA, RN, Will Be Featured in the Worldwide Leaders in HealthcareMarch 23rd, 2017
- Arboviral Infections Pose Serious Risks to Patients on RituximabJanuary 23rd, 2024